September 2023
More than 60 members received no- or reduced- cost mammograms during ACN’s three Community Health Fairs in West Phoenix, Goodyear, and Mesa during the month of September.
In partnership with Adelante Healthcare, SimonMed, and Alignment Health, the Community Health Fairs were offered to members covered under ACN’s various payer arrangements, including Mercy Care, but were also open to the public. Members reserved a screening day/time through a link shared by email and on ACN’s Facebook page.
ACN-participating providers, along with the Care Coordination team and ACN’s population health pharmacist, were on-site to answer any member questions. Games, a food truck, blood pressure screening, free giveaways, and other health resource documents were also available.
Thank you to everyone who participated and stay tuned for possible future community health fairs in 2024.
![]()
Arizona Care Network’s physician-led Board of Managers is accepting nominations through Nov. 1, 2023, for three-year terms beginning in 2024.
Board meetings are conducted at ACN’s office in Phoenix unless a virtual meeting is deemed more appropriate. Meetings are held at 6 p.m. on the first Thursday of alternate months beginning in April (April, June, August, October, and December).
A stipend for participation is offered. Additional information on Board member roles and responsibilities is available here.
If you or a participating physician would like to be considered by the Nominating Committee, please download and submit a nomination form via email governance@azcarenetwork.org by Nov. 1, 2023.
![]()
To improve its quality measurement and reporting, the National Committee for Quality Assurance (NCQA) is revising and retiring a few HEDIS measures for the 2024 measurement year.
Ultimately, HEDIS retired four measures, updated diabetes measures and made smaller changes across multiple measures. The NCQA also continues the transition to Electronic Clinical Data Systems (ECDS) reporting.
Only the ECDS reporting method will be used for these measures.
View the full HEDIS technical specifications for more information.
Please contact your Clinical Performance Consultant or email practicetrasnsformation@azcarenetwork.org with any questions about HEDIS and quality measures.
![]()
Three new vaccines are available to your patients this fall: a COVID-19 booster, a respiratory syncytial virus (RSV) vaccine, and updated flu shots.
The CDC recommends anyone age 6 months or older receive a COVID-19 vaccine if they previously have not or receive the updated COVID-19 booster from either Pfizer or Moderna.
With approximately six months of peak effectiveness, the CDC recommends patients receive booster vaccines in late October, a few weeks before peak season for COVID and flu begins in November. The CDC also recommends eligible patient receive the RSV vaccine two weeks after the flu/COVID vaccines.
The CDC also says these vaccines are available at no-cost to most patients with health insurance. Those without insurance may be eligible for free vaccinations through local pharmacies, or local health centers that participate in the Bridge Access Program.
Need additional support? ACN’s Care Coordination team can help your patients schedule any vaccine or booster appointments. Call (602) 406-7226 or email carecoordination@azcarenetwork.org for additional patient support.
![]()
Earlier this summer, ACN expanded its partnership with UnitedHealthcare, adding a new value-based arrangement that offers practices in the network additional incentive opportunities for patients covered under UHC Community & State (C&S) Medicaid plan.
This addition of C&S to ACN’s portfolio of value-based arrangements creates an opportunity for primary care practices to include their C&S members in the 2024 Provider Rewards Program (PRP), while providing further opportunities to increase member attribution for primary care and specialist practices.
PRP-eligible practices may participate with both Mercy Care and UHC’s C&S programs simultaneously to further increase your practice’s incentive opportunities.
Please contact your Clinical Performance Consultant or email practicetransformation@azcarenetwork.org by mid-October to learn more about this opportunity and ask any questions.
![]()
Earlier this summer, all Abrazo Health and United Surgical Partners International (USPI) facilities became in-network options for Medica (Pinnacle) members.
This network expansion provides more than 50 additional locations throughout the Valley.
Previously, only Dignity Health, Valleywise Health, and Phoenix Children’s Care Network were considered in-network for Medica (Pinnacle) members.
Providers and members may now locate Abrazo and USPI locations within ACN’s Find-a-Provider website tool, along with all other ACN-participant practices and facilities. Your practice may also call ACN’s Concierge Team at (602) 406-7226 to confirm a medical group’s network status.
Please contact your Clinical Performance Consultants or email practicetransformation@azcarenetwork.org to receive any Quality measure tip sheet or with questions.
![]()
As chlamydia and other sexually transmitted diseases continue to increase among women in the United States, preventative screening is crucial toward early detection and treatment, especially for sexually active women in their teens through mid-20s.
For women ages 21-65, cervical cancer screening is a simple and important first step toward prevention, of, if necessary, treatment. And it can begin with asking patients a simple question: “Have you recently been sexually active?”
These screenings among your female patient population not only close important quality gaps, but can save time, medical costs, and even lives.
Cervical Cancer tip sheet (.PDF)
Chlamydia Screening tip sheet (.PDF)
Additional 1-page tip sheets are available to your practice for a wide variety of wellness and preventative care situations, including:
Need support? ACN can help patients schedule a chlamydia or cervical cancer screening with your practice by calling
(602) 406-7226 or email members@azcarenetwork.org.
Please contact your Clinical Performance Consultant or email practicetransformation@azcarenetwork.org to receive any
1-page tip sheets.
![]()
Tannaz Farahani, PharmD, MPH
Manager, Population Health Pharmacy
Arizona Care Network
As of Jan. 1, 2022, several Payors (Aetna, Optum, UHC, et al.) increased the maximum day supply of certain medications from 90 to 100 days.
There are some important caveats related to this recent benefit increase:
A best practice for these situations could be to write a new 100-day supply prescription for maintenance medications for all patients. If they are not approved, they will be added to patient’s profile as additional refills.
Not all medications can be dispensed as a 100-day supply:
1. Unbreakable packages such as inhalers, vials, or tubes, etc. – some medications may be limited by State and Federal Quantity Limitations
2. Specialty-tier medications (ie. Tier 5 medications continue to be a maximum 30-day supply),
3. Short-term medications – Antibiotics, Pain Medications, etc.
4. Extended day supply may not be appropriate.
If a member continues to fill a 90-day supply, the claims will continue to adjudicate normally.
Providers and patients can contact the dispensing pharmacy with any questions or to confirm a medication’s maximum daily supply allowance.
![]()
Tannaz Farahani, PharmD, MPH
Manager, Population Health Pharmacy
Arizona Care Network
Pharmacy laws and practices vary from state to state, particularly when it comes to managing interchangeable biosimilars.
In Arizona, if the medical provider who prescribes the biologic does not indicate an intent to prevent substitution, then substitution would be allowed by the dispensing pharmacist.
“Interchangeable biological product” means a biological product that either:
A pharmacist in Arizona may substitute a biological product for a prescribed biological product only if all the following conditions are met:
Within five (5) business days after dispensing a biological product, the dispensing pharmacist:
With “biosimilars” doing well and a wave of biosimilar products arriving into the U.S. market constantly, it is important to know where and how to access reliable information to aid in the decision making when prescribing the right biosimilar. For example, this year alone the U.S. market will potentially see as many as 10 adalimumab biosimilars (Humira).
The FDA has a searchable online database called the Purple Book, which is a dedicated list of licensed biological products, biosimilar and interchangeable biological products, licensed and approved by the FDA under the Public Health Service Act.
Visit the FDA’s Purple Book Database
![]()
![]()
You can also view a list of provider organizations no longer participating with ACN.![]()